First of its Kind Therapy for Parkinson’s Disease Advances to Phase 2b Trials
By Daniel Ojeda, Ph.D. On October 20th, Prothena Corporation plc. and Roche announced they would advance Prasinezumab, a treatment for Parkinson’s Disease, into Phase 2b clinical trials. Prasinezumab is the …
Read More